Lee, Y., Lee, H., Park, H., Kim, J., Hwang, J., Kim, J., . . . Kim, H. (2017). Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas. Oncotarget.
Citação norma ChicagoLee, Yangkyu, Hyejung Lee, Hyunjin Park, Jin-Won Kim, Jin-Hyeok Hwang, Jaihwan Kim, Yoo-Seok Yoon, Ho-Seong Han, and Haeryoung Kim. "Combination Immunohistochemistry for SMAD4 and Runt-related Transcription Factor 3 May Identify a Favorable Prognostic Subgroup of Pancreatic Ductal Adenocarcinomas." Oncotarget 2017.
Citação norma MLALee, Yangkyu, et al. "Combination Immunohistochemistry for SMAD4 and Runt-related Transcription Factor 3 May Identify a Favorable Prognostic Subgroup of Pancreatic Ductal Adenocarcinomas." Oncotarget 2017.